UpHealth (UPHL)
OTHER OTC:UPHL
Top Page
No summary available
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for UpHealth's digital health solutions, suggesting a solid market position and potential for future expansion.
Negative Factors
Profitability Challenges
Ongoing profitability issues highlight operational inefficiencies, which could hinder long-term sustainability and investor confidence.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Consistent revenue growth indicates strong demand for UpHealth's digital health solutions, suggesting a solid market position and potential for future expansion.
Read all positive factors
UpHealth (UPHL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.79K
Dividend YieldN/A
Average Volume (3M)10.68K
Price to Earnings (P/E)―
Beta (1Y)-58.97
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees374
SectorHealthcare
Sector Strength45
IndustryMedical - Equipment & Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,932,192
10 Day Avg. Volume10,683
30 Day Avg. Volume10,683
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.07
Price to Sales (P/S)0.03
P/FCF Ratio-0.19
Enterprise Value/Market Cap38.90K
Enterprise Value/Revenue1.68
Enterprise Value/Gross Profit3.52
Enterprise Value/Ebitda-7.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UpHealth Business Overview & Revenue Model
Company Description
UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also pr...
How the Company Makes Money
UpHealth makes money through a diversified revenue model that includes subscription fees for its digital health platforms, service fees for telehealth consultations, and licensing fees for its integrated care management solutions. The company also...
UpHealth Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.85M | 130.00M | 158.80M | 123.80M | 5.40M | 0.00 |
| Gross Profit | 41.88M | 69.59M | 54.02M | 30.54M | 3.89M | 0.00 |
| EBITDA | -20.73M | -16.90M | -183.99M | -305.61M | -1.60M | -953.44K |
| Net Income | -77.44M | -57.84M | -223.00M | -341.02M | -2.19M | 360.45K |
Balance Sheet | ||||||
| Total Assets | 269.73M | 231.81M | 339.80M | 569.31M | 262.39M | 175.77M |
| Cash, Cash Equivalents and Short-Term Investments | 170.34M | 2.55M | 15.56M | 76.80M | 2.37M | 1.58M |
| Total Debt | 149.91M | 153.32M | 160.46M | 126.55M | 23.30M | 0.00 |
| Total Liabilities | 187.95M | 176.70M | 233.67M | 235.46M | 41.67M | 339.96K |
| Stockholders Equity | 81.78M | 55.10M | 105.15M | 318.46M | 220.72M | 175.43M |
Cash Flow | ||||||
| Free Cash Flow | -22.83M | -21.64M | -29.28M | -66.54M | -1.14M | -1.48M |
| Operating Cash Flow | -20.20M | -17.67M | -22.44M | -62.82M | -1.14M | -1.48M |
| Investing Cash Flow | 191.60M | 15.26M | -15.59M | 743.00K | 3.51M | -172.12M |
| Financing Cash Flow | -14.39M | -10.60M | -22.75M | 135.87M | 0.00 | 175.18M |
UpHealth Risk Analysis
UpHealth disclosed 57 risk factors in its most recent earnings report. UpHealth reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
UpHealth Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $3.79K | ― | -104.96% | ― | ― | ― | |
66 Neutral | $2.79B | 14.42 | 46.60% | 1.27% | ― | ― | |
61 Neutral | $4.23B | 77.60 | 1.52% | ― | 4.73% | ― | |
47 Neutral | $511.28M | -16.87 | -24.45% | ― | 67.01% | -39.19% |
* Healthcare Sector Average
UPHL
UpHealth
―
―
―
NVST
Envista Holdings
25.84
8.87
52.27%
PFSA
Profusa
0.53
-892.72
-99.94%
CON
Concentra Group Holdings Parent, Inc.
21.70
0.50
2.37%
BBNX
Beta Bionics, Inc.
11.52
-0.19
-1.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―